Condition
Cancer of Unknown Primary Site clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Cancer of Unknown Primary Site clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
F520 with paclitaxel and carboplatin as first-line therapy for cancer of unknown primary
This trial tests whether adding F520 to standard chemotherapy can improve responses in adults with cancer of unknown primary who have not yet received systemic therapy.
-
Targeting rare cancers with genomic therapy
This study is testing if personalized treatments based on the genetic makeup of rare tumors can help patients feel better and improve their outcomes.
Related topics
Quick answers
How many Cancer of Unknown Primary Site clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.